retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 for Obesity: Weight-Loss Data 💉 A triple-action once-weekly injection

Today, GLP-1 drugs account for about 15% of monthly revenue in practices that offer them, and approximately 40% of patients receiving GLP-1 treatments in 2024 were new to those practices

You also have to wait 30 minutes before eating, drinking or taking other medications

KANEKO, Shizuka

Diabetologia 59(7):14121421 Tonneijck L, Muskiet MHA, Smits MM, Hoekstra T, Kramer MHH, Danser AHJ et al (2017) Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: an 8-week, randomised, open-label trial

GLP-1 receptor activation slows gastric emptying

In the DURATION-3 trial, the clinical efficacy of once-weekly exenatide was estimated and compared to that of insulin glargine for 26 weeks